Clinical Trials

65 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT05684874 2023-10-30

SarQuantIRM

25 enrolled

Sarcoma

Pathologic Complete Response, Neoplasms, Sarcoma

NCT04126590 2023-09-01

Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors

Phase 1 Unknown

39 enrolled

Pathologic Complete Response

NCT05925751 2023-06-29

Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer

Thoracic

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT05763992 2023-05-18

BREAKFAST-2

145 enrolled

Pathologic Complete Response, Breast Neoplasms, Fasting, Triple Negative Breast Neoplasms

NCT05750693 2023-03-02

PIK3CA in HER2+ BC and pCR Trial

58 enrolled

Pathologic Complete Response, Hereditary Sensory and Autonomic Neuropathies

NCT04278274 2022-10-26

MR-AI-pCR

205 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT05441098 2022-07-01

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

1,821 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT04457700 2022-04-18

CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC

218 enrolled

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04781725 2021-11-17

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

90 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT05050890 2021-09-30

GIRO_ctDNA

38 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT04917263 2021-06-08

IMMUNOREACT2

544 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT02907827 2020-12-17

DW-MRi

Dermatologic

Pathologic Complete Response, Melanoma

NCT03474341 2020-11-16

PRIDE

200 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Pathologic Complete Response, Esophageal Neoplasms

NCT03417427 2020-04-27

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT04273477 2020-02-18

MRAI-pCR

Pathologic Complete Response, Rectal Neoplasms

NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

44 enrolled

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

NCT01863862 2019-03-29

Organ Preservation in Elderly Patients With Rectal Cancer

90 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT01830244 2017-07-02

Neonab

60 enrolled

Other hematologic neoplasm

Pathologic Complete Response, Breast Neoplasms

NCT01520558 2017-06-29

CNDO-109-AANK for AML in First Complete Remission (CR1)

Phase 1/2 Unknown

12 enrolled 11 charts

Pathologic Complete Response, Leukemia, Myeloid, Acute

NCT02511847 2016-04-15

Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of Afatinib

40 enrolled

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02059876 2014-02-12

Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer

60 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT01134484 2012-07-20

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

Phase 3 Unknown

480 enrolled

Plasma cell

Pathologic Complete Response, Multiple Myeloma

NCT01566799 2012-03-30

Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer